Search by Drug Name or NDC
NDC 24208-0446-02 Besivance 6 mg/mL Details
Besivance 6 mg/mL
Besivance is a OPHTHALMIC SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is BESIFLOXACIN.
MedlinePlus Drug Summary
Besifloxacin ophthalmic is used to treat bacterial conjunctivitis (pinkeye; infection of the membrane that covers the outside of the eyeballs and the inside of the eyelids). Besifloxacin is in a class of medications called fluoroquinolones. It works by killing the bacteria that cause infection.
Related Packages: 24208-0446-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Besifloxacin Ophthalmic
Product Information
| NDC | 24208-0446 |
|---|---|
| Product ID | 24208-446_2b3a99b3-0edb-428b-ae41-67d297956a65 |
| Associated GPIs | 86101007101820 |
| GCN Sequence Number | 065230 |
| GCN Sequence Number Description | besifloxacin HCl DROPS SUSP 0.6 % OPHTHALMIC |
| HIC3 | Q6W |
| HIC3 Description | OPHTHALMIC ANTIBIOTICS |
| GCN | 24317 |
| HICL Sequence Number | 036350 |
| HICL Sequence Number Description | BESIFLOXACIN HCL |
| Brand/Generic | Brand |
| Proprietary Name | Besivance |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Besifloxacin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 6 |
| Active Ingredient Units | mg/mL |
| Substance Name | BESIFLOXACIN |
| Labeler Name | Bausch & Lomb Incorporated |
| Pharmaceutical Class | Quinolone Antimicrobial [EPC], Quinolones [CS] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA022308 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24208-0446-02 (24208044602)
| NDC Package Code | 24208-446-02 |
|---|---|
| Billing NDC | 24208044602 |
| Package | 1 BOTTLE, DROPPER in 1 CARTON (24208-446-02) / 2 mL in 1 BOTTLE, DROPPER |
| Marketing Start Date | 2009-05-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |